Grifols introduces its new fibrinogen concentrate Fesilty in the US
Grifols has begun marketing its new fibrinogen concentrate Fesilty in the United States, indicated for the treatment of acute bleeding in adult and pediatric patients with congenital fibrinogen deficiency (CFD), which includes hypo- or afibrinogenemia, although it is not approved for cases of dysfibrinogenemia.CFD is a rare hereditary disorder that...
5 minutos